Pediatric hepatocellular carcinoma (HCC) and fibrolamellar carcinoma are rare, aggressive forms of liver cancer that typically affect adolescents and young adults. Although some immunotherapy drugs are approved by the Food ...
Aug 30, 2024
0
30
The cells that make up cancerous brain tumors are extremely varied and sometimes create unique three-dimensional shapes. As far back as 1932, American neurosurgeon Percival Bailey attempted to label these cells and discovered ...
Aug 29, 2024
0
11
Investigators have discovered that aberrant activation of a specific oncoprotein drives key tumor-promoting changes in the prostate tissue microenvironment during cancer progression, according to a Northwestern Medicine study ...
Aug 29, 2024
0
19
An innovative software tool could advance cancer pathology by providing diagnostic insights from tissue biopsies. The tool, called METI (Morphology-Enhanced Spatial Transcriptome Analysis Integrator), was developed by researchers ...
Aug 29, 2024
0
16
Researchers at the University of Massachusetts Amherst and UMass Chan Medical School have demonstrated in mice a new method to combat pancreatic cancer. The study, published in Science Translational Medicine, outlines the ...
Aug 28, 2024
0
54
Salt could help to boost the immune defense against cancer. This is suggested by the research findings of a team led by Prof. Dr. Christina Zielinski, who holds the Chair of Infection Immunology at the Friedrich Schiller ...
Aug 28, 2024
0
73
The fight against cancer is an arms race, and one of the most effective weapons in clinicians' arsenals is immunotherapy. Immune checkpoint therapy has become the standard for treating several types of cancer. However, the ...
Aug 26, 2024
0
47
A new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and Boston Children's Hospital and published in Nature Immunology shows how tumors grow by avoiding the immune system.
Aug 26, 2024
0
47
What are the characteristics of a cancer cell that are recognized by the immune system? Knowledge of the potential target structures for the immune cells is a basic prerequisite for the development of personalized cancer ...
Aug 22, 2024
0
20
A new report describes a promising approach to studying neurofibromatosis type 1 (NF1), a genetic condition with limited treatment options. The condition causes a number of different cancerous and non-cancerous tumors to ...
Aug 22, 2024
0
0
